Juliana C. S. Chaves

A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies

A. Pébay, J. Götz, Lotta E. Oikari, 2022, bioRxiv.

Modeling the Blood–Brain Barrier to Understand Drug Delivery in Alzheimer’s Disease

Lotta E. Oikari, Anthony R. White, J. Wasielewska, 2020, Alzheimer’s Disease: Drug Discovery.

A patient-derived blood-brain barrier model for screening copper bis(thiosemicarbazone) complexes as potential therapeutics in Alzheimer’s disease

J. Koistinaho, Lotta E. Oikari, Anthony R. White, 2023, bioRxiv.

Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.

Lotta E. Oikari, Juliana C. S. Chaves, Samantha J. Dando, 2023, Biochimica et biophysica acta. Molecular basis of disease.

Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound

J. Koistinaho, Lotta E. Oikari, Carla Cuní-López, 2023, Neurotherapeutics.

Increased tau expression in the APOE4 blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery in vitro

A. Pébay, Lotta E. Oikari, Rinie Bajracharya, 2023, bioRxiv.

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer's Disease.

J. Koistinaho, Lotta E. Oikari, Lachlan E. McInnes, 2024, ACS chemical neuroscience.